-
WES of 2 human osteosarcoma and corresponding cell lines
Study
EGAS00001003923
-
Sequencing data of multiple sarcoma samples for personalized medicine and endotype identification
Study
EGAS00001003981
-
SCC ctDNA sequencing
Study
EGAS00001003987
-
SCC tumor sequencing
Study
EGAS00001003988
-
MYO5B mutations in Pheochromocytoma/Paraganglioma promote cancer progression
Study
EGAS00001003991
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
Myeloma RNAseq
Study
EGAS00001003999
-
Myeloma WGS
Study
EGAS00001004000
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
A Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling
Study
EGAS00001004018